Respiratory News and Research

RSS

$Study evaluates effectiveness of surgical vs nonsurgical treatment for proximal humeral fractures$

Study evaluates effectiveness of surgical vs nonsurgical treatment for proximal humeral fractures

Among patients with a displaced fracture in the upper arm near the shoulder (proximal humeral), there was no significant difference between surgical treatment and nonsurgical treatment in patient-reported outcomes over two years following the fracture, results that do not support the trend of increased surgery for patients with this type of fracture, according to a study in the March 10 issue of JAMA.

10 Mar 2015

Inhaled Nitric Oxide still being used in preterm neonates despite evidence of short-term benefit

Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.

10 Mar 2015

Halyard Health releases improved placement kit for PEG tube

Halyard Health, formerly Kimberly-Clark Health Care, today announced the introduction of an improved placement kit for its Percutaneous Endoscopic Gastrostomy (PEG) tube, the MIC* PEG tube. The components of the kit have been organized to align with the procedural steps for tube placement.

9 Mar 2015

Blood gas testing: an interview with David Stein, PhD, CEO, Point of Care, Siemens Healthcare Diagnostics

The industry term ‘blood gas testing’ has come to mean the accurate measurement and reporting of a wide menu of blood parameters, all on a single platform.

From Siemens Healthineers Point of Care Diagnostics 9 Mar 2015

FDA approves Astellas' CRESEMBA for treatment of invasive aspergillosis, invasive mucormycosis

Astellas today announced that the U.S. Food and Drug Administration has approved its New Drug Application (NDA) for the use of CRESEMBA (isavuconazonium sulfate), the prodrug for isavuconazole, for patients 18 years of age and older in the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis).

8 Mar 2015

Adults only really catch flu about twice a decade, suggests study

Adults over the age of 30 only catch flu about twice a decade, a new study suggests. Flu-like illness can be caused by many pathogens, making it difficult to assess how often people are infected by influenza.

6 Mar 2015

Preventing lung infections in childhood could help people with cystic fibrosis during adulthood

Preventing lung infections in childhood could stop later life-threatening infections for people with cystic fibrosis (CF), according to the latest research carried out at Aston University.

6 Mar 2015

European launch of the Proxima miniature in-line blood gas analyser at ISICEM 2015

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its ground-breaking in-line patient dedicated arterial blood gas analyser in Germany, Netherlands and Belgium at ISICEM 2015.

5 Mar 2015

Mallinckrodt enters into definitive agreement to acquire Ikaria

Mallinckrodt plc, a leading global specialty biopharmaceutical company, and Ikaria, Inc. a privately-held critical care company, announced today that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Ikaria, Inc. from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion.

5 Mar 2015

Symbiomix Therapeutics announces positive results from SYM-1219 Phase 1 clinical program

Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical program demonstrating that its lead product candidate, SYM-1219, was safe and well tolerated and had predictable pharmacokinetics (PK), and that contraceptive efficacy for birth control pills would not be altered by SYM-1219 administration.

4 Mar 2015

Reducing premature deaths from noncommunicable diseases: an interview with Dr Shanthi Mendis, WHO

The main types of NCD are cardiovascular disease, cancer, chronic respiratory diseases and diabetes. These have been identified as the principal conditions for three main reasons. One is that, collectively, they contribute the most to the total disease burden.

4 Mar 2015

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Halyard Health, Inc. today reported year-end 2014 results and provided its 2015 outlook and related key planning assumptions.

4 Mar 2015

Novogen's TRXE-009 therapy shows promise against brain cancer

Australian/US biotechnology company, Novogen Limited, today announces that it has confirmed that one of its lead candidate products, TRXE-009, is showing the potential to become an important new therapy in the fight against adult and pediatric brain cancer.

4 Mar 2015

UF researchers find that people with brain tumor fare better with personal insurance

Brain tumor patients who are uninsured or use Medicaid stay hospitalized longer and develop more medical complications than those with private insurance, University of Florida Health researchers have found.

4 Mar 2015

Life expectancy for Spaniards increases due to 'cardiovascular revolution'

Over the last century, life expectancy for Spaniards has increased by 40 years. A study by the International University of La Rioja highlights the main cause, since 1980, as being the reduced incidence of cardiovascular diseases while other pathologies, such as mental illnesses and certain types of cancer, have been seen to rise. The authors predict that the effects of the economic recession on mortality will show up in the long-term.

4 Mar 2015

Kansas State researchers preparing for next potential influenza strain

As seasonal influenza cases decrease across the United States, Kansas State University researchers are preparing for the next potential virulent strain of flu.

4 Mar 2015

BUSM researchers discover genes involved in formation of lung tumors

The lung transcription factor Nkx2-1 is an important gene regulating lung formation and normal respiratory functions after birth. Alterations in the expression of this transcription factor can lead to diseases such as lung interstitial disease, post-natal respiratory distress and lung cancer.

3 Mar 2015

Study reports 10% reduction in overall C-section births in Portugal

A new study reports a significant decline in the rate of cesarean section (C-section) births in Portugal. Findings published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, indicate a 10% reduction in overall C-section rates between 2009 and 2014, with a 14% reduction in state-hospitals during the same time period.

2 Mar 2015

New algorithm can gauge long-term death risk based on treadmill exercise performance

Analyzing data from 58,000 heart stress tests, Johns Hopkins cardiologists report they have developed a formula that estimates one's risk of dying over a decade based on a person's ability to exercise on a treadmill at an increasing speed and incline.

2 Mar 2015

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Mundipharma International Limited’s network of independent associated companies are launching Remsima® (infliximab) this month in Germany, Italy, UK, Netherlands, Belgium and Luxembourg following expiry of the relevant patents and Supplementary Protection Certificates, having secured distribution rights from Celltrion Healthcare Hungary Kft for Remsima in these markets.

1 Mar 2015

Respiratory News and Research

Study evaluates effectiveness of surgical vs nonsurgical treatment for proximal humeral fractures

Inhaled Nitric Oxide still being used in preterm neonates despite evidence of short-term benefit

Halyard Health releases improved placement kit for PEG tube

Blood gas testing: an interview with David Stein, PhD, CEO, Point of Care, Siemens Healthcare Diagnostics

FDA approves Astellas' CRESEMBA for treatment of invasive aspergillosis, invasive mucormycosis

Adults only really catch flu about twice a decade, suggests study

Preventing lung infections in childhood could help people with cystic fibrosis during adulthood

European launch of the Proxima miniature in-line blood gas analyser at ISICEM 2015

Mallinckrodt enters into definitive agreement to acquire Ikaria

Symbiomix Therapeutics announces positive results from SYM-1219 Phase 1 clinical program

Reducing premature deaths from noncommunicable diseases: an interview with Dr Shanthi Mendis, WHO

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Novogen's TRXE-009 therapy shows promise against brain cancer

UF researchers find that people with brain tumor fare better with personal insurance

Life expectancy for Spaniards increases due to 'cardiovascular revolution'

Kansas State researchers preparing for next potential influenza strain

BUSM researchers discover genes involved in formation of lung tumors

Study reports 10% reduction in overall C-section births in Portugal

New algorithm can gauge long-term death risk based on treadmill exercise performance

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News